BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28754820)

  • 21. Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
    Tucunduva L; Ruggeri A; Sanz G; Furst S; Cornelissen J; Linkesch W; Mannone L; Ribera JM; Veelken H; Yakoub-Agha I; González Valentín ME; Schots R; Arcese W; Montesinos P; Labopin M; Gluckman E; Mohty M; Rocha V
    Br J Haematol; 2014 Sep; 166(5):749-57. PubMed ID: 24961645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units.
    Yin Y; Ren HY; Cen XA; Qiu ZX; Ou JP; Wang WS; Wang MJ; Xu WL; Wang LH; Li Y; Dong YJ
    Chin Med J (Engl); 2011 Aug; 124(16):2411-6. PubMed ID: 21933579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
    Rio B; Chevret S; Vigouroux S; Chevallier P; Fürst S; Sirvent A; Bay JO; Socié G; Ceballos P; Huynh A; Cornillon J; Françoise S; Legrand F; Yakoub-Agha I; Michel G; Maillard N; Margueritte G; Maury S; Uzunov M; Bulabois CE; Michallet M; Clement L; Dauriac C; Bilger K; Gluckman E; Ruggeri A; Buzyn A; Nguyen S; Simon T; Milpied N; Rocha V;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):445-53. PubMed ID: 25460357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire.
    Xavier E; Cornillon J; Ruggeri A; Chevallier P; Cornelissen JJ; Andersen NS; Maillard N; Nguyen S; Blaise D; Deconinck E; Veelken H; Milpied N; Van Gelder M; Peffault de Latour R; Gluckman E; Kröger N; Schetelig J; Rocha V
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1515-23. PubMed ID: 25958294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto-SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
    Chevallier P; Labopin M; Socie G; Rubio MT; Blaise D; Vigouroux S; Huynh A; Michallet M; Bay JO; Maury S; Yakoub-Agha I; Fegueux N; Deconinck E; Contentin N; Maillard N; Bulabois CE; Francois S; Oumedaly R; Raus N; Mohty M
    Eur J Haematol; 2015 May; 94(5):449-55. PubMed ID: 25238651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord/ALWP-EBMT and JSHCT/JDCHCT collaborative study.
    Kanda J; Hayashi H; Ruggeri A; Kimura F; Volt F; Takahashi S; Labopin M; Kako S; Tozatto-Maio K; Yano S; Sanz G; Uchida N; Van Lint MT; Kato S; Mohty M; Forcade E; Kanamori H; Sierra J; Ohno Y; Saccardi R; Fukuda T; Ichinohe T; Takanashi M; Rocha V; Okamoto S; Nagler A; Atsuta Y; Gluckman E
    Leukemia; 2020 Jan; 34(1):128-137. PubMed ID: 31409921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation.
    Rodrigues CA; Sanz G; Brunstein CG; Sanz J; Wagner JE; Renaud M; de Lima M; Cairo MS; Fürst S; Rio B; Dalley C; Carreras E; Harousseau JL; Mohty M; Taveira D; Dreger P; Sureda A; Gluckman E; Rocha V
    J Clin Oncol; 2009 Jan; 27(2):256-63. PubMed ID: 19064984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients.
    Zhang H; Chen J; Que W
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1164-73. PubMed ID: 22289799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
    Sanz J; Montesinos P; Saavedra S; Lorenzo I; Senent L; Planelles D; Larrea L; Martín G; Palau J; Jarque I; Martínez J; de la Rubia J; Moscardó F; Martinez D; Gómez I; López M; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1589-95. PubMed ID: 20553927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
    Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
    Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Umbilical cord blood transplantation for acute myeloid leukemia.
    Advani AS; Laughlin MJ
    Curr Opin Hematol; 2009 Mar; 16(2):124-8. PubMed ID: 19468274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decitabine prior to salvaged unrelated cord blood transplantation for refractory or relapsed childhood acute leukemia.
    Zhou H; Zheng C; Zhu X; Tang B; Tong J; Zhang X; Zhang L; Liu H; Sun Z
    Pediatr Transplant; 2016 Dec; 20(8):1117-1124. PubMed ID: 27620713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
    Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease.
    Balligand L; Galambrun C; Sirvent A; Roux C; Pochon C; Bruno B; Jubert C; Loundou A; Esmiol S; Yakoub-Agha I; Forcade E; Paillard C; Marie-Cardine A; Plantaz D; Gandemer V; Blaise D; Rialland F; Renard C; Seux M; Baumstarck K; Mohty M; Dalle JH; Michel G
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):734-742. PubMed ID: 30385256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
    Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
    Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission.
    Yanada M; Kanda J; Ohtake S; Fukuda T; Sakamaki H; Miyamura K; Miyawaki S; Uchida N; Maeda T; Nagamura-Inoue T; Asou N; Morishima Y; Atsuta Y; Miyazaki Y; Kimura F; Kobayashi Y; Takami A; Naoe T; Kanda Y
    Eur J Haematol; 2016 Sep; 97(3):278-87. PubMed ID: 26680003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.
    Ruggeri A; Battipaglia G; Labopin M; Ehninger G; Beelen D; Tischer J; Ganser A; Schwerdtfeger R; Glass B; Finke J; Michallet M; Stelljes M; Jindra P; Arnold R; Kröger N; Mohty M; Nagler A
    J Hematol Oncol; 2016 Sep; 9(1):89. PubMed ID: 27639553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia.
    Kuwatsuka Y; Kanda J; Yamazaki H; Mori T; Miyamura K; Kako S; Uchida N; Ohashi K; Ozawa Y; Takahashi Y; Kato C; Iwato K; Ishiyama K; Kobayashi H; Eto T; Kahata K; Kato J; Miyamoto T; Kato K; Mori S; Atsuta Y; Kimura F; Kanda Y;
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1836-1843. PubMed ID: 27401034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.